In response, the sustained activation of IRE1α and ATF6 branches driven by MEK/ERK pathway endows tumor cells with enhanced survival capacity [50, 51], with the involvement of the activation of downstream autophagy, mitochondrial fission, mitophagy and JAK/ STAT3 pathway [11, 17, 18, 52]. This evidence concerns the gene MAP2K7 and neoplasm.